Imagine IT

Imagine Pharma is a biotechnology company focused on developing innovative therapies using its proprietary IMG-1 platform, which leverages a unique peptide derived from alpha-1-antitrypsin (AAT). The company's lead programs target Type 1 diabetes through the development of Activated Insulin Producing Cells (AIPCs), which aim to restore insulin production in patients. Additionally, Imagine Pharma is advancing an oral delivery system for biologics and exploring regenerative medicine applications for various inflammatory and autoimmune conditions. By combining advanced cell therapy with novel peptide-based delivery mechanisms, the company seeks to provide transformative treatments for chronic diseases with high unmet medical needs.